Literature DB >> 24939730

Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics.

Shohreh Nikoo1, Massoumeh Ebtekar2, Mahmood Jeddi-Tehrani3, Adel Shervin1, Mahmood Bozorgmehr4, Sedigheh Vafaei4, Somayeh Kazemnejad5, Amir-Hassan Zarnani6.   

Abstract

Retrograde flow of menstrual blood cells during menstruation is considered as the dominant theory for the development of endometriosis. Moreover, current evidence suggests that endometrial-derived stem cells are key players in the pathogenesis of endometriosis. In particular, endometrial stromal stem cells have been suggested to be involved in the pathogenesis of this disease. Here, we aimed to use menstrual blood, as a novel source of endometrial stem cells, to investigate whether stromal stem cells from endometriosis (E-MenSCs) and non-endometriosis (NE-MenSCs) women differed regarding their morphology, CD marker expression pattern, proliferation, invasion and adhesion capacities and their ability to express certain immunomodulatory molecules. E-MenSCs were morphologically different from NE-MenSCs and showed higher expression of CD9, CD10 and CD29. Furthermore, E-MenSCs had higher proliferation and invasion potentials compared with NE-MenSCs. The amount of indoleamine 2,3-dioxygenase-1 (IDO1) and cyclooxygenase-2 (COX-2) in E-MenSCs co-cultured with allogenic peripheral blood mononuclear cells (PBMCs) was shown to be higher both at the gene and protein levels, and higher IDO1 activity was detected in the endometriosis group. However, NE-MenSCs revealed increased concentrations of forkhead transcription factor-3 (FOXP3) when compared with E-MenSCs. Nonetheless, interferon (IFN)-γ, Interleukin (IL)-10 and monocyte chemoattractant protein-1 (MCP-1) levels were higher in the supernatant of E-MenSCs-PBMC co-cultures. Here, we showed that there are inherent differences between E-MenSCs and NE-MenSCs. These findings propose the key role MenSCs could play in the pathogenesis of endometriosis and further support the retrograde and stem cell theories of endometriosis. Hence, considering its renewable and easily available nature, menstrual blood could be viewed as a reliable and inexpensive material for studies addressing the cellular and molecular aspects of endometriosis.
© The Author 2014. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  IDO1; endometriosis; menstrual blood; stromal stem cells; surface marker expression

Mesh:

Substances:

Year:  2014        PMID: 24939730     DOI: 10.1093/molehr/gau044

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  25 in total

1.  IL-1β Inhibits Connexin 43 and Disrupts Decidualization of Human Endometrial Stromal Cells Through ERK1/2 and p38 MAP Kinase.

Authors:  Jie Yu; Sarah L Berga; Wei Zou; D Grace Yook; Joshua C Pan; Aurora Arroyo Andrade; Lijuan Zhao; Neil Sidell; Indrani C Bagchi; Milan K Bagchi; Robert N Taylor
Journal:  Endocrinology       Date:  2017-12-01       Impact factor: 4.736

2.  Overexpression of miR-200b-3p in Menstrual Blood-Derived Mesenchymal Stem Cells from Endometriosis Women.

Authors:  Rafael Zucco de Oliveira; Fabiana de Oliveira Buono; Ana Clara Lagazzi Cressoni; Letícia Bruna Corrêa Penariol; Cristiana Carolina Padovan; Patricia Aparecida Tozetti; Omero Benedito Poli-Neto; Rui Alberto Ferriani; Maristela Delgado Orellana; Júlio Cesar Rosa-E-Silva; Juliana Meola
Journal:  Reprod Sci       Date:  2022-01-24       Impact factor: 3.060

Review 3.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

4.  Endometrial Stromal Decidualization Responds Reversibly to Hormone Stimulation and Withdrawal.

Authors:  Jie Yu; Sarah L Berga; Erika B Johnston-MacAnanny; Neil Sidell; Indrani C Bagchi; Milan K Bagchi; Robert N Taylor
Journal:  Endocrinology       Date:  2016-04-01       Impact factor: 4.736

Review 5.  Somatic stem cells and their dysfunction in endometriosis.

Authors:  Dusan Djokovic; Carlos Calhaz-Jorge
Journal:  Front Surg       Date:  2015-01-06

6.  Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells.

Authors:  Zahra Rasoulzadeh; Roya Ghods; Tohid Kazemi; Ebrahim Mirzadegan; Nassim Ghaffari-Tabrizi-Wizsy; Simin Rezania; Somaieh Kazemnejad; Soheila Arefi; Jamileh Ghasemi; Sedigheh Vafaei; Ahmad-Reza Mahmoudi; Amir-Hassan Zarnani
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

7.  Exosomes derived from human menstrual blood-derived stem cells alleviate fulminant hepatic failure.

Authors:  Lu Chen; Bingyu Xiang; Xiaojun Wang; Charlie Xiang
Journal:  Stem Cell Res Ther       Date:  2017-01-23       Impact factor: 6.832

8.  Mesenchymal Stromal Cells Are More Immunosuppressive In Vitro If They Are Derived from Endometriotic Lesions than from Eutopic Endometrium.

Authors:  Fawaz Abomaray; Sebastian Gidlöf; Cecilia Götherström
Journal:  Stem Cells Int       Date:  2017-11-05       Impact factor: 5.443

9.  Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators.

Authors:  Lijun Chen; Chunfeng Zhang; Lu Chen; Xiaojun Wang; Bingyu Xiang; Xiaoxing Wu; Yang Guo; Xiaozhou Mou; Li Yuan; Bo Chen; Jinfu Wang; Charlie Xiang
Journal:  Stem Cells Transl Med       Date:  2016-07-28       Impact factor: 6.940

10.  Menstrual Blood-Derived Endometrial Stem Cells' Impact for the Treatment Perspective of Female Infertility.

Authors:  Giedrė Skliutė; Raminta Baušytė; Veronika Borutinskaitė; Giedrė Valiulienė; Algirdas Kaupinis; Mindaugas Valius; Diana Ramašauskaitė; Rūta Navakauskienė
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.